See the DrugPatentWatch profile for immune
What is Rh Immune Globulin Intravenous (Human)?
Rh immune globulin intravenous (human), also known as RhIG, is a medication used to prevent Rh sensitization in Rh-negative individuals. It is administered to prevent the immune system from producing antibodies against Rh-positive red blood cells. This is particularly important during pregnancy when an Rh-negative mother carries an Rh-positive fetus, or in cases of mismatched blood transfusions.
Licensed Sources of Rh Immune Globulin Intravenous (Human)
The primary licensed sources for Rh immune globulin intravenous (human) in the United States are manufactured by CSL Plasma, Inc. and Grifols USA. These products are derived from human plasma and are regulated by the U.S. Food and Drug Administration (FDA).
How Does Rh Immune Globulin Work?
RhIG contains antibodies that bind to and neutralize Rh-positive red blood cells that may enter the Rh-negative person's bloodstream. This prevents the Rh-negative individual's immune system from recognizing these foreign cells as a threat and mounting an immune response.
When is Rh Immune Globulin Administered?
RhIG is typically administered to Rh-negative individuals in several situations:
* During Pregnancy: It is given to Rh-negative pregnant women around the 28th week of gestation and again within 72 hours after delivery if the baby is Rh-positive.
* After Potentially Sensitizing Events: It is also given after events that could lead to a mixing of fetal and maternal blood, such as miscarriage, abortion, ectopic pregnancy, amniocentesis, chorionic villus sampling, or abdominal trauma during pregnancy.
* After Transfusion: In cases where an Rh-negative person has received Rh-positive blood, RhIG may be administered to prevent sensitization.
What are the Risks of Rh Sensitization?
Rh sensitization can lead to hemolytic disease of the fetus and newborn (HDFN) in future Rh-positive pregnancies. HDFN can cause severe anemia, jaundice, brain damage, and even death in newborns.
Who Manufactures Rh Immune Globulin?
CSL Plasma, Inc. and Grifols USA are the key manufacturers of licensed Rh immune globulin intravenous (human) products.
What are the Regulatory Requirements for Rh Immune Globulin?
Products are licensed by the U.S. Food and Drug Administration (FDA) and must meet strict manufacturing and quality control standards. This includes ensuring the safety and efficacy of the plasma-derived product.
Are There Alternatives to Rh Immune Globulin?
Currently, Rh immune globulin is the standard of care for preventing Rh sensitization. There are no widely available or licensed alternatives that offer the same preventive mechanism.
What is the Typical Cost of Rh Immune Globulin?
The cost of Rh immune globulin can vary depending on the product, dosage, and healthcare provider. Insurance coverage also plays a significant role in out-of-pocket expenses for patients.
Where Can I Find More Information on Drug Patents and Exclusivity?
Information regarding drug patents and market exclusivity, which can influence the availability and pricing of medications, can be found on sites like DrugPatentWatch.com [1].
Sources
1. https://drugpatentwatch.com/